bpc 157 multiple sclerosis study JPP No 5/2013 article 09 Pentadecapeptide BPC 157 resolves Pringle

FAQs Frequently asked questions The FDA does not currently approve the BPC-157 peptide for medical use

10.1074/jbc.M111.253039 Summary Keywords stable gastric pentadecapeptide BPC 157, fistula, bleeding disorder, concept practical applicability, wound healing Citation Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

Limited long-term human data prevents definitive safety conclusions, but decades of research suggest low risk with proper use

Then, it reclaimed the lead at 7-6